Cafepharma | Pharmaceutical Sales, Medical Sales, Lab Sales

Cafepharma Today

June 2 2023 - Novartis drug helps stop breast cancer’s return in large study

Novartis drug helps stop breast cancer’s return in large study
Pfizer says antibiotic is effective against tough-to-treat infections
Medicare outlines plan to expand coverage for costly new Alzheimer’s drugs
Supreme Court vetoes efforts to limit anti-fraud law aimed at government contractors
*please scroll down for all the latest news*

Current News

submit a press release

Click here to stay updated on CP happenings

Moderna looks for opportunities in China after registering legal entity

Reuters

Tuesday, May 30, 2023 - 9:55am

tags:

Moderna Therapeutics, China

EMA Panel Endorses Novavax's (NVAX) COVID vaccine for Full Approval

Yahoo/Zacks.com

Tuesday, May 30, 2023 - 9:52am

tags:

Novavax, EMA, Europe, vaccines, CHMP, COVID-19

How tranScrip CEO Marcin Mankowski is ‘driving forward’ drug innovation and development

Biopharma Reporter

Tuesday, May 30, 2023 - 9:49am

tags:

tranScrip, drug development, innovation, Marcin Mankowski

Hummingbird Bioscience Announces HMBD-002 Trials in Progress Poster at ASCO Annual Meeting 2023

BioSpace

Tuesday, May 30, 2023 - 9:47am

tags:

Hummingbird Biosciences, HMBD-002, cliincal trials, ASCO 2023, triple-negative breast cancer, non-small cell lung cancer

Pfizer's Heading for a Patent Cliff

Motley Fool

Tuesday, May 30, 2023 - 9:45am

tags:

Pfizer, patents, patent cliff

Xilio reports preliminary data from Phase I solid tumors therapy trial

Clinical Trials Arena

Tuesday, May 30, 2023 - 9:40am

tags:

Xilio Therapeutics, clinical trials, solid tumors, XTX101

Gilead, Teva reach 11th-hour settlements with some groups in HIV antitrust case

Fierce Pharma

Monday, May 29, 2023 - 12:26pm

tags:

Gilead Sciences, Teva Pharmaceutical, HIV, legal, antitrust

AstraZeneca reports positive results from endometrial cancer therapy trial

Clinical Trials Arena

Monday, May 29, 2023 - 12:24pm

tags:

AstraZeneca, endometrial cancer, clinical trials, Imfinzi, Lynparza

Harbour reports results from HCC combo therapy trial

Clinical Trials Arena

Monday, May 29, 2023 - 12:23pm

tags:

Harbour BioMed, porustobart, HCC, hepatocellular carcinoma, clinlcal trials

Elon Musk’s Neuralink clears FDA hurdle, gears up for human trials

Medical Marketing and Media

Monday, May 29, 2023 - 12:17pm

tags:

Neuralink, FDA, clinical trials, brain implants, Elon Musk

Lexicon gets FDA approval for Inpefa to treat heart failure

Pharmaceutical Technology

Monday, May 29, 2023 - 12:14pm

tags:

Lexicon Pharmaceuticals, FDA, Inpefa, heart failure

Johnson & Johnson cites rebates and discounts for drug price increases

Fierce Pharma

Monday, May 29, 2023 - 12:09pm

tags:

JNJ, drug pricing, drug rebates, drug discounts

Boston Sci Scraps Majority Stake Deal with M.I. Tech

Medical Devices and Diagnostics Industry

Monday, May 29, 2023 - 12:07pm

tags:

Medtech, Boston Scientific, M&A, MI Tech

FDA grants priority review for Takeda and HUTCHMED’s fruquintinib NDA

Pharmaceutical Technology

Friday, May 26, 2023 - 11:31am

tags:

Takeda, Hutchmed, FDA, fruquintinib, colorectal cancer

Slump in medtech VC activity continues as inflation keeps investors on the sidelines

BioPharma Dive

Friday, May 26, 2023 - 11:19am

tags:

Medtech, funding, venture capital

Pfizer’s etrasimod aims to differentiate UC market with strong safety profile

Clinical Trials Arena

Friday, May 26, 2023 - 11:12am

tags:

Pfizer, etrasimod, ulcerative colitis

AstraZeneca's drug combo shows positive results in late-stage cancer trial

Reuters

Friday, May 26, 2023 - 10:09am

tags:

ASCO 2023, AstraZeneca, Imfinzi, Lynparza, endometrial cancer

Noom to offer prescriptions for weight-loss drugs

Yahoo Finance

Friday, May 26, 2023 - 10:05am

tags:

Noom, weightloss, Novo Nordisk, Eli Lilly, Wegovy, Ozempic, Mounjaro

Integra recalls all devices made at Boston facility in the past 5 years, pauses production

Medtech Dive

Friday, May 26, 2023 - 10:02am

tags:

Integra LifeSciences, devices, Medtech, device recalls, postoperative fever

ASCO: BMS pitches Breyanzi as the first CAR-T for CLL. But will a single-arm trial persuade the FDA?

Fierce Pharma

Friday, May 26, 2023 - 9:57am

tags:

ASCO 2023, Bristol Myers Squibb, Breyanzi, CAR-T, CLL, SLL, clinical trials

Pages

Latest CP Wire Articles

Eastman introduces new excipient to formulate poorly soluble API

Most-clicked pharma news for week ending April 1 2023: Signify Health acquisition, Ferring Research Institute shutdown, Jardiance sales increase, and more

PharmaBlock Receives 2023 ACS CMO Excellence in Green Chemistry Award

PharmaBlock Opens New R&D Facility in Pennsylvania ——Expanding Capacity to Deliver GMP Projects

Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy

Most-clicked pharma news for week ending March 18 2023: Medtronic offers early retirement package, Novartis to sell ophthalmological assets, and Pfizer tops list of drugs with price increases

Klick Health launches new healthcare venture studio

Medtech earnings reports: insights from major players' Q4 results

Key compliance issues for medtech firms transitioning to data-enabled solutions

Following FDA COVID vaccine advisory panel vote, Novavax is prepared to provide a revised vaccine

Latest Pharmagather Articles

The Drug Discount Ecosystem’s “Mission Critical”

Drug Channels

Fakin' It the Modern Way

In the Pipeline

Reduction of Tau

In the Pipeline

Timeless

In the Pipeline

Drug Channels News Roundup, May 2023: 340B Shame, OptumRx vs. Humira Biosimilars, ICER on White Bagging, Hospitals vs. Taxes, and Dr. G

Drug Channels

AI and the Hard Stuff

In the Pipeline

Break Out the Purple Carrots

In the Pipeline

Five (or Maybe Six?) Reasons that the Largest PBMs Operate Group Purchasing Organizations

Drug Channels

Give Me Those Hard, Hard Numbers

In the Pipeline